Abstract
Context To encourage Covid-19 vaccination, France introduced during the Summer 2021 a “Sanitary Pass,” which morphed into a “Vaccine Passe” in early 2022. While the Sanity Pass led to an increase in Covid-19 vaccination rates, spatial heterogeneities in vaccination rates remained. To identify potential determinants of these heterogeneities and evaluate the French Sanitary and Vaccine Pass’ efficacies in reducing them, we used a data-driven approach on exhaustive nationwide data, gathering 141 socio-economic, political and geographic indicators.
Methods We considered the association between being a district above the median value of the first-dose vaccination rates and being above the median value of each indicator at different time points: just before the sanitary pass announcement (week 2021-W27), just before the sanitary pass came into force (week 2021-W31) and one month after (week 2021-W35), and the equivalent dates for the vaccine pass (weeks 2021-W49, 2022-W03, 2022-W07). We then considered the change over time of vaccination rates according to deciles of the three of the most associated indicators.
Results The indicators most associated with vaccination rates were the share of local income coming from unemployment benefits, the proportion of overcrowded households, the proportion of immigrants in the district, and vote for an “anti-establishment” candidate at the 2017 Presidential election. Vaccination rate also were also contrasted along a North-West – South East axis, with lower vaccination coverage in the South-East of France.
Conclusion Our analysis reveals that, both before and after the introduction of the French sanitary and vaccination passes, factors with the largest impact are related to poverty, immigration, and trust in the government.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
EL received funding to match socio-economic data with medical data from AP-HP Centre Universite de Paris.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involves only openly available data: - INSEE: https://www.insee.fr/fr/statistiques/5359146#consulter - Assurance Maladie: https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/ - 2017 Presidential election: https://www.data.gouv.fr/fr/datasets/election-presidentielle-des-23-avril-et-7-mai-2017-resultats-definitifs-du-1er-tour-par-communes/#resource-d282e53a-d273-425d-95bb-8a0d7632c79a-header The data are published by official French institutions, are only available in aggregated format, and therefore are not individual data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The study has been extended to include the Vaccine Passport, as well as indicators on the results of the 2017 Presidential election
Data Availability
This study involves only openly available data: - INSEE: https://www.insee.fr/fr/statistiques/5359146#consulter - Assurance Maladie: https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/ - 2017 Presidential election: https://www.data.gouv.fr/fr/datasets/election-presidentielle-des-23-avril-et-7-mai-2017-resultats-definitifs-du-1er-tour-par-communes/#resource-d282e53a-d273-425d-95bb-8a0d7632c79a-header
https://www.insee.fr/fr/statistiques/5359146#consulter
https://datavaccin-covid.ameli.fr/explore/dataset/donnees-devaccination-par-epci/
https://datavaccin-covid.ameli.fr/explore/dataset/donnees-de-vaccination-parcommune/information/
